View of Development of CL184 human monoclonal antibody combination for rabies post-exposure prophylaxis, from preclinical design to clinical evaluation

Return to Article Details Development of CL184 human monoclonal antibody combination for rabies post-exposure prophylaxis, from preclinical design to clinical evaluation Download Download PDF